phenyl-1-p-tolylimino-allyl)-phosphonate 5a (329 mg, 1.0 mmol),
affording 278 mg (84%) of 6a as a pale yellow oil. Rf (AcOEt):
0.60. 1H NMR (300 MHz, CDCl3): δ 2.21 (s, 3 H, CH3), 3.77 (d,
3JPH ) 10.7 Hz, 3 H, OCH3), 3.80 (d, 3JPH ) 10.5 Hz, 3 H, OCH3),
3.89 (broad s, 1H, NH), 4.44 (ddd, 4JHH ) 1.5 Hz, 3JHH ) 6.3 Hz,
2JPH ) 25.6 Hz, 1 H, CHN), 6.22 (ddd, 3JPH ) 5.2 Hz, 3JHH ) 6.3
unsaturated carbonyl compounds 4, avoiding the undesirable
Michael addition (1,4-addition), is required. This methodology
applied to â,γ-unsaturated R-ketophosphonates 4 provides access
to R,â-unsaturated imines derived from R-aminophosphonates
5, molecules that are described here for the first time. Moreover,
regioselective reduction (1,2-addition) of the imine carbon-
nitrogen double bond of R,â-unsaturated imines derived from
R-aminophosphonates 5 proves to be a general method for the
preparation of vinylogous R-aminophosphonates 6, whereas total
reduction of both double bonds (carbon-nitrogen and carbon-
carbon) of R,â-unsaturated imines 5 gives R-aminophosphonates
7. Likewise primary R-aminophosphonates 8 and 9 can be
obtained by selective N-deprotection of the amino group.
R-Amino-phosphonate derivatives are important building blocks
in organic synthesis1 and in the preparation of biologically active
compounds of interest in medicinal chemistry.2
3
3
Hz, JHH ) 15.8 Hz, 1 H, CHd), 6.60 (d, JHH ) 8.5 Hz, 2 H, 2
4
4
3
× CHar), 6.69 (ddd, JHH ) 1.5 Hz, JPH ) 4.9 Hz, JHH ) 15.8
3
Hz, 1 H, CHd), 6.97 (d, JHH ) 8.5 Hz, 2 H, 2 × CHar), 7.20-
7.35 (m, 5H, 5 × CHar). 13C NMR (75 MHz, CDCl3): δ 20.3
2
2
(CH3), 53.4 (d, JPC ) 7.6 Hz, OCH3), 53.9 (d, JPC ) 7.1 Hz,
OCH3), 54.0 (d, 1JPC ) 154.6 Hz, CHN), 113.9 (2 × CHar), 123.3
(d, 2JPC ) 4.5 Hz, CHd), 126.6 (2 × CHar), 127.8 (CHar), 127.9
3
(Cquat), 128.4 (2 × CHar), 129.7 (2 × CHar), 133.3 (d, JPC
10.0 Hz, CHd), 136.1 (d, 4JPC ) 4.0 Hz, Cquat), 143.9 (d, 3JPC
)
)
12.6 Hz, Cquat). 31P NMR (120 MHz, CDCl3): δ 25.9. FTIR (KBr)
νmax (cm-1): 3310 (N-H st), 1229 (PdO st). CIMS m/z (amu):
332 ([M+ + H], 74), 222 ([M+] - PO(OMe)2, 100). Anal. Calcd
for C18H22NO3P: C 65.25; H 6.69; N 4.23. Found: C 65.31; H
6.75; N 4.16.
Experimental Section
General Procedure. Synthesis R-Aminophosphonates 7. A
solution of R,â-unsaturated imine 5 or vinylogous R-aminophos-
phonate 6 (0.5 mmol) in EtOH (5 mL) with Pd-C (10%) (32 mg,
0.03 mmol) was stirred for 2 days under H2 atmosphere at 80 psi.
The resulting mixture was filtered through celite and concentrated
under reduced pressure. The crude residue was purified by
chromatography (SiO2, AcOEt/pentane 3:1).
General Procedure. Synthesis of R,â-Unsaturated Imines 5
Derived from R-Aminophosphonate. To a solution of the corre-
sponding azide 3 (2.0 mmol) in toluene (10 mL) at 0 °C was added
a 1.0 M solution of trimethylphosphine in toluene (2 mL). The
resulting solution was stirred 30 min until N2 evolution stopped,
which indicates the completion of the reaction and phosphazene 1
formation and can be monitored by 31P NMR. The corresponding
neat â,γ-unsaturated R-ketophosphonate 2 (2.0 mmol) was then
added, and the reaction was stirred for an additional 30 min at room
temperature. R,â-Unsaturated imines 5d,e were used without any
further workup as a toluene solution. For the workup of the reactions
corresponding to R,â-unsaturated imines 5a-c, the solution was
diluted with CH2Cl2 (40 mL), washed with water (3 × 20 mL),
dried over MgSO4 and concentrated under reduced pressure to
afford a yellow oily crude that was purified by chromatography
(SiO2, AcOEt/pentane 3:1).
Dimethyl (3-Phenyl-1-p-tolylamino-propyl)-phosphonate 7a.
Synthesized according to the general procedure from dimethyl (3-
phenyl-1-p-tolylimino-allyl)-phosphonate 5a (165 mg, 0.5 mmol),
affording 258 mg (88%) of 7a as a colorless oil. Synthesized
according to the general procedure from dimethyl (3-phenyl-1-p-
tolylamino-allyl)-phosphonate 6a (167 mg, 0.5 mmol), affording
1
0.241 mg (91%) of 7a as a colorless oil. Rf (AcOEt): 0.67. H
NMR (300 MHz, CDCl3): δ 1.97 (m, 1 H, CH2), 2.20 (m, 1 H,
CH2), 2.22 (s, 3 H, CH3), 2.72 (m, 1 H, CH2), 2.88 (m, 1 H, CH2),
Dimethyl (3-Phenyl-1-p-tolylimino-allyl)-phosphonate 5a. Syn-
thesized according to the general procedure with p-tolylazide (266
mg, 2 mmol) and diethyl (3-phenyl-acryloyl)-phosphonate (480 mg,
2 mmol), affording 407 mg (89%) of 5a as a yellow oil. Rf.
(AcOEt): 0.57. 1H NMR (300 MHz, CDCl3): δ 2.35 (s, 3 H, CH3),
3.92 (d, 3JPH ) 10.8 Hz, 6 H, 2 × OCH3), 6.77 (d, 3JHH ) 8.1 Hz,
3
3
3.67 (d, JPH ) 11.0 Hz, 3 H, OCH3), 3.71 (d, JPH ) 11.1 Hz, 3
H, OCH3), 3.80 (m, 1 H, CHN), 6.50 (d, 3JHH ) 8.4 Hz, 2 H, 2 ×
3
CHar), 6.98 (d, JHH ) 8.4 Hz, 2 H, 2 × CHar), 7.12-7.16 (m,
2H, 2 × CHar), 7.19-7.30 (m, 3H, 3 × CHar). 13C NMR (75 MHz,
3
CDCl3): δ 20.6 (CH3), 32.2 (d, JPC ) 12.1 Hz, CH2), 32.6 (d,
2JPC ) 4.5 Hz, CH2), 50.5 (d, JPC ) 155.1 Hz, CHN), 52.8 (d,
1
3
3
2 H, 2 × CHar), 6.78 (dd, JHH ) 16.6 Hz, JPH ) 38.4 Hz, 1 H,
2JPC ) 7.1 Hz, OCH3), 53.8 (d, 2JPC ) 7.1 Hz, OCH3), 113.8 (2 ×
3
CHd), 7.15 (d, JHH ) 8.1 Hz, 2 H, 2 × CHar), 7.28-7.30 (m,
CHar), 126.3 (CHar), 127.7 (Cquat), 128.7 (2 × CHar), 128.9 (2
3
2H, 2 × CHar), 7.35-7.38 (m, 3 H, 3 × CHar), 7.85 (d, JHH
)
3
× CHar), 130.0 (2 × CHar), 141.1 (Cquat), 144.8 (d, JPC ) 5.0
16.6 Hz, 1 H, CHd). 13C NMR (75 MHz, CDCl3): δ 21.2 (CH3),
Hz, Cquat). 31P NMR (120 MHz, CDCl3): δ 29.8. FTIR (KBr)
νmax (cm-1): 3297 (N-H st), 1228 (PdO st). CIMS m/z (amu):
334 ([M+ + H], 77), 224 ([M+] - PO(OMe)2, 100). Anal. Calcd
for C18H24NO3P: C 64.85; H 7.26; N 4.20. Found: C 64.95; H
7.33; N 4.15.
2
3
54.2 (d, JPC ) 7.1 Hz, 2 × OCH3), 119.7 (d, JPC ) 33.2 Hz,
CHd), 120.5 (2 × CHar), 128.1 (2 × CHar), 129.0 (2 × CHar),
129.8 (2 × CHar), 130.1 (CHar), 135.3 (Cquat), 135.8 (Cquat),
3
1
142.8 (CdH), 147.0 (d, JPC ) 31.2 Hz, Cquat), 162.9 (d, JPC
)
214.5 Hz, CdN). 31P NMR (120 MHz, CDCl3): δ 10.8. FTIR (KBr)
νmax (cm-1): 1613 (CdN st), 1255 (PdO st). CIMS m/z (amu):
330 ([M+ + H], 100), 220 ([M+] - PO(OMe)2, 78). Anal. Calcd
for C18H20NO3P: C 65.65; H 6.12; N 4.25. Found: C 65.71; H
6.05; N 4.27.
Acknowledgment. The present work has been supported by
the Direccio´n General de Investigacio´n del Ministerio de Ciencia
y Tecnolog´ıa (MCYT, Madrid DGI, CTQ2006-09323) and by
the Universidad del Pa´ıs Vasco (UPV, GIU 06/51). J.V. thanks
the Departamento de Educacio´n, Universidades e Investigacio´n
del Gobierno Vasco for a postdoctoral fellowship. Drs. J. M.
de los Santos and C. Alonso are gratefully acknowledged for
their assistance with 2D NMR experiments.
General Procedure. Selective Reduction of R,â-Unsaturated
Imines 5 with BH3.SMe2. Synthesis of Vinylogous R-Amino-
phosphonates 6. To a solution of R,â-unsaturated imine 5 (1.0
mmol) in toluene (5 mL) at -78 °C was added a 1.0 M solution of
BH3‚SMe2 in CH2Cl2 (1.5 mL, 1.5 mmol). The reaction was stirred
at -78 °C for 3 h, quenched with a saturated aqueous solution of
NaHCO3, and allowed to warm to room temperature. The resulting
mixture was diluted in CH2Cl2 (20 mL), washed with water (3 ×
20 mL), dried over MgSO4, and concentrated under reduced
pressure. The crude residue was purified by chromatography (SiO2,
AcOEt/pentane 3:1).
Supporting Information Available: Procedures and full char-
acterization for compounds 5b-e, 6b-e, 7a-c, 8, and 9. This
material is available free of charge via the Internet at http://
pubs.acs.org.
Dimethyl (3-Phenyl-1-p-tolylamino-allyl)-phosphonate 6a.
Synthesized according to the general procedure with dimethyl (3-
JO062609+
J. Org. Chem, Vol. 72, No. 7, 2007 2685